Electrocore LLC Asset Resilience Ratio
Electrocore LLC asset resilience ratio. Electrocore LLC (ECOR) has an Asset Resilience Ratio of 9.04% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ECOR cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Electrocore LLC (2017–2025)
Asset resilience ratio of Electrocore LLC from 2017 to 2025. This chart shows how Electrocore LLC's Asset Resilience Ratio has changed over time. Read Electrocore LLC (ECOR) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Electrocore LLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ECOR current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.54 Million | 9.04% |
| Total Liquid Assets | $1.54 Million | 9.04% |
Asset Resilience Insights
- Limited Liquidity: Electrocore LLC maintains only 9.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Electrocore LLC Industry Peers by Asset Resilience Ratio
Compare Electrocore LLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Electrocore LLC Asset Resilience Ratio by Year (2017–2025)
Electrocore LLC asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Electrocore LLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 24.51% | $4.58 Million | $18.67 Million | -17.10pp |
| 2024-12-31 | 41.61% | $8.52 Million | $20.47 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $16.10 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $42.83 Million | -- |
| 2020-12-31 | 58.34% | $18.39 Million | $31.52 Million | +28.74pp |
| 2019-12-31 | 29.60% | $10.50 Million | $35.46 Million | -53.34pp |
| 2018-12-31 | 82.94% | $60.96 Million | $73.50 Million | +21.89pp |
| 2017-12-31 | 61.05% | $23.95 Million | $39.23 Million | -- |
About Electrocore LLC
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic… Read more